MK-8591A: payments to doctors
Payments that named MK-8591A as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $95K
- Providers
- 40
- Transactions
- 373
- Average per transaction
- $255
The per-transaction average — $255 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 40 providers the average total is $2,380, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $95,216 | 100.0% |